Collaborations
The Society for Immunotherapy of Cancer (SITC) recognizes that collaborations are an essential component to driving the field of cancer immunotherapy forward, and therefore seeks to expand its impact establishing relationships with like-minded organizational partners. Through these relationships, SITC creates channels of information exchange. SITC has established project-driven and long-standing collaborative relationships with numerous domestic and international organizations, including the following associations and organizations, government and regulatory agencies, patient advocacy organizations and foundations.
Associations & Organizations
Domestic
- Advanced Medical Technology Association (AdvaMed)
- Advancing Transfusion and Cellular Therapies Worldwide (AABB)
- AIDS Clinical Trials Group (ACTG)
- American Association for Cancer Research (AACR)
- American Association of Immunologists (AAI)
- American Cancer Society Cancer Action Network (ACS CAN)
- American Society for Blood and Marrow Transplantation (ASBMT)
- American Society for Radiation Oncology (ASTRO)
- American Society for Cell Biology (ASCB)
- American Society of Clinical Oncology (ASCO)
- American Society of Gene and Cell Therapy (ASCGT)
- American Society of Hematology (ASH)
- Association of American Cancer Centers
- Association of Northern California Oncologists (ANCO)
- Association of Community Cancer Centers (ACCC)
- Association of Oncology Social Workers (AOSW)
- Biotechnology Industry Organization (BIO)
- Cancer Immunotherapy Consortium (CIC)-Cancer Research Institute (CRI)
- Clinical Immunology Society (CIS)
- College of American Pathologists (CAP)
- Commission on Cancer (CoC)
- Community Oncology Alliance (COA)
- Federation of Clinical Immunology Societies (FOCIS)
- Foundation for the Accreditation of Cellular Therapy (FACT)
- Hematology Oncology Pharmacists Association (HOPA)
- International Association for the Study of Lung Cancer (IASLC)
- International Society for Cellular Therapy (ISCT)
- Keystone Symposia
- Kidney Cancer Association (KCA)
- National Coalition for Cancer Research (NCCR)
- National Comprehensive Cancer Network (NCCN)
- National Coalition of Oncology Nurse Navigators (NCONN)
- Ohio Hematology Oncology Society (OHOS)
- Oncology Specialty Group (OSG)
- Tumor Vaccine and Cell Therapy Working Group (TVACT)
International
- Adoptive Engineered T Cell Targeting to Activate Cancer Killing (ATTACK), France
- Arab Medical Association Against Cancer (AMAAC), Egypt
- Association for Immunotherapy of Cancer (CIMT), Germany
- Canadian Cancer Immunotherapy Consortium (CCIC), Canada
- Cancer Drug Development Forum (CDDF), Germany
- Cancer Immunotherapy and Immunomonitoring (CITIM)
- Center for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC), Sweden
- Chinese American Hematologist Oncologist Network (CAHON), China
- Chinese Anti-Cancer Association (CACA), China
- Chinese Immunotherapy and Immunomonitoring (CITIM), China
- Chinese Immunotherapy Trials Network (CITN), China
- Chinese Society of Clinical Oncology (CSCO), China
- Chinese Society for Immunology (CSI), China
- Committee for Tumor Immunology and Bio-Therapy (TIBT), China
- Dutch Tumor Immunology Working Party (DTIWP), The Netherlands
- European Academy of Tumor Immunology (EATI), France
- European Cancer Organisation (ECCO)
- European Congress of Immunology (ECI), United Kingdom
- European Society of Cancer Immunology and Immunotherapy (ESCII), Greece
- European Society for Medical Oncology (ESMO)
- Fondazione Melanoma ONLUS, Italy
- German Cancer Immunology group in the German Immunology Society (DGFI), Germany
- Grupo Español de Terapias Inmuno-Biológicas en Cáncer (GÉTICA), Spain
- International Society for Cellular Therapy (ISCT), Canada
- Istituto Nazionale Tumori Fondazione G. Pascale, Italy
- Italian Melanoma Intergroup (IMI), Italy
- Italian Network for Tumor Biotherapy (NIBIT), Italy
- Japanese Association of Cancer Immunotherapy (JACI), Japan
- National Institute of Oncology, Budapest, Hungary
- Progress in Vaccination Against Cancer (PIVAC), Europe
- Royal Society of London, England
- Scandinavian Network for Immunotherapy of Cancer (SNIC), Scandinavia
- Sidra Medical and Research Center, Qatar
- Swiss Institute for Experimental Cancer Research (ISREC), Switzerland
- Tumor Immunology Meets Oncology (TIMO)
Government & Regulatory Agencies
Domestic
- Cancer Immunotherapy Trials Network (CITN)
- Cancer Moonshot Blue Ribbon Panel
- Cancer Therapy Evaluation Program (CTEP)
- Food and Drug Administration (FDA)
- National Cancer Institute (NCI)
- National Heart, Lung and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- Production Assistance for Cellular Therapy (PACT)
International
- Center for Drug Evaluation, (SFDA), P.R. China
- Department of Biotechnology (DBT), Government of India
- European Medicines Agency (EMEA), United Kingdom
- Health Canada, Canada
- Japan Science and Technology Agency (JST), Japan
- Paul-Ehrlich-Institut (PEI), Germany
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
- State Food and Drug Administration (SFDA), P.R. China
- Swissmedic, Swiss Agency for Therapeutic Products, Switzerland
Patient Advocacy Organizations & Foundations
- AIM at Melanoma
- Bonnie J. Addario Lung Cancer Foundation
- Cancer Support Community (CSC)
- Cancer Research Institute (CRI)
- Friends of Cancer Research Foundation
- Gilda’s Club
- Global Resource for Advancing Cancer Education (GRACE)
- Immuno-Oncology Policy Working Group
- LUNGevity
- Lung Cancer Alliance (LCA)
- Melanoma Foundation
- Melanoma Research Alliance (MRA)
- Melanoma Research Foundation (MRF)
- Patient Advocates in Research (PAIR)
- Prostate Cancer Foundation (PCF)
- Research Advocacy Network (RAN)
- Research!America
- Skin of Steel
- Solving Kids’ Cancer
- Stand Up To Cancer (SU2C)